Work

Pmu56 Impact of Fda Approval of New Agents on Therapeutic Options for Genetic Variants in Pediatric Tumors

Year: 2020

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2020.04.828

Authors: H. Russell, H. Smith, F. Lin, A. Roy, S. Plon, W. Parsons

Institution: Baylor College of Medicine

Language: English

Topic: Genomics and Rare Diseases

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3026693297

Cites:

Cited by:

Related to: 10